Poll: 1 in 5 US adults report trouble affording prescription drugs

Poll: 1 in 5 US adults report trouble affording prescription drugs
© istock

About 1 in 5 U.S. adults say that they or someone in their household has been unable to afford drugs that were prescribed to them in the past 12 months, according to a new poll from Gallup and West Health. 

The survey found that 22.9 percent of U.S. adults said there had been a time in the past year when their household was unable to pay for drugs they were prescribed, up from 18.9 percent in January. 

ADVERTISEMENT

The poll illustrates the struggles many Americans have paying for medication at a time when lowering drug prices is an intense subject of debate in Washington. 

President TrumpDonald John TrumpCuomo grilled by brother about running for president: 'No. no' Maxine Waters unleashes over Trump COVID-19 response: 'Stop congratulating yourself! You're a failure' Meadows resigns from Congress, heads to White House MORE has railed against high drug prices and has proposed some steps, including linking certain Medicare drug prices to lower ones paid in other countries, but he has not taken any major action that has gone into effect yet. 

The Gallup survey finds the public is mostly negative on Trump’s performance on the issue so far, with 66 percent of adults saying he has done “not very much” or “none at all” to fight high drug prices. Twenty percent said he had done a “fair amount” and 7 percent said “a great deal.”

Speaker Nancy PelosiNancy PelosiMeadows resigns from Congress, heads to White House Pelosi floats undoing SALT deduction cap in next coronavirus bill Overnight Health Care: More states order residents to stay at home | Trump looks to sell public on coronavirus response | Judges block Ohio, Texas abortion bans | Dems eye infrastructure in next relief bill MORE (D-Calif.) is pushing a sweeping bill to allow the secretary of Health and Human Services to negotiate lower prices on up to 250 drugs per year. Republicans oppose that measure, warning it would hinder the development of new treatments, but some are supporting smaller measures like a bill in the Senate from Sens. Chuck GrassleyCharles (Chuck) Ernest GrassleyDemocrats eye additional relief checks for coronavirus Coronavirus pushes GOP's Biden-Burisma probe to back burner Lobbying blitz yields wins for airlines, corporations, banks, unions MORE (R-Iowa) and Ron WydenRonald (Ron) Lee WydenHillicon Valley: FCC chief proposes 0M telehealth program | Twitter takes down posts promoting anti-malaria drugs for coronavirus| Whole Foods workers plan Tuesday strike Trump says election proposals in coronavirus stimulus bill would hurt Republican chances States should plan now for November voting options MORE (D-Ore.). 

Drug companies say that the problem is insurers and pharmacy benefit managers who are not passing discounts they receive on to consumers.